Feb 8 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2016 Dec 31, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 49.04 47.05 66.00
(+4.2 pct) (+2.8 pct) (+5.6 pct)
Operating 3.64 3.79 4.80
(-4.0 pct) (+13.5 pct) (+5.1 pct)
Recurring 3.50 3.77 4.60
(-7.0 pct) (+13.0 pct) (+3.4 pct)
Net 2.87 3.34 3.60
(-13.8 pct) (+5.5 pct) (+2.5 pct)
EPS 54.10 yen 62.79 yen 67.78 yen
Ann Div 31.00 yen 32.00 yen
-Q2 div 16.00 yen 15.00 yen
-Q4 div 16.00 yen 16.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T
((Tokyo Headline News Desk +813 6441 1812))